Celanese Raises 2026 Free Cash Flow Outlook After Strong Q3

Celanese Corporation (NYSE: CE) raised its full-year 2026 free cash flow guidance to $750 million to $800 million after generating $461 million in the third quarter, as commercial discipline, productivity measures and stronger business execution supported cash generation despite automotive weakness and higher raw-material costs.

The specialty materials and chemicals company reported third-quarter adjusted earnings of $1.65 per share. Adjusted EBIT was $209 million in Engineered Materials and $236 million in Acetyl Chain. Celanese said its differentiated business models, growth initiatives and productivity benefits drove the quarter’s results.

Free cash flow reached $604 million for the first nine months of 2026. The company expects the third quarter to remain its strongest cash-generating quarter of the year, similar to the pattern in 2025. Celanese generated $773 million of free cash flow in 2025 and $498 million in 2024.

Engineered Materials expands margins

Engineered Materials delivered a richer sales mix and year-over-year margin expansion, with targeted growth programs and commercial execution offsetting raw-material inflation and weakness in automotive markets.

The segment has focused on higher-margin applications in medical products and electronics. Excluding Micromax, which was divested in February 2026, Engineered Materials’ net sales increased 5% year over year in the third quarter. Sales to medical and electronics applications rose 30%, following 16% growth in the second quarter.

Celanese highlighted opportunities for its engineering polymers in patient-monitoring devices and AI infrastructure, including liquid crystal polymers used in high-speed connectors and thermal-management applications. The company is commissioning compounding enhancements intended to support these higher-margin products.

Engineered Materials generated $663 million of adjusted EBIT through the first nine months. Celanese projects full-year segment adjusted EBIT of $833 million to $853 million, representing growth of 16% to 18% from $720 million in 2025. Fourth-quarter adjusted EBIT is expected to be between $170 million and $190 million.

Acetyl Chain benefits from Western Hemisphere execution

Acetyl Chain posted year-over-year adjusted EBIT growth, supported by execution in the Western Hemisphere and the company’s downstream-focused business model. Western Hemisphere sales accounted for 73% of the segment’s net sales in the third quarter, compared with 61% in 2021.

Celanese said converting acetic acid into downstream products such as emulsion polymers and redispersible powders provides higher margin contributions. The company is also commissioning a downstream vinyl acetate ethylene reactor and targeting building and construction applications.

For the fourth quarter, Celanese expects Acetyl Chain adjusted EBIT of $200 million to $230 million. Management plans to pursue margin opportunities in the Western Hemisphere as supply-related opportunities normalize, while accounting for regional seasonality and demand that remains stable at lower levels.

Cost reductions, divestitures and debt repayment remain priorities

Celanese is targeting about $175 million of incremental cost reductions across 2026 and 2027, including roughly $100 million of improvement in 2027 as lower net interest expense begins to contribute. The initiatives cover Engineered Materials cost programs, Acetyl Chain footprint and productivity measures, lower functional expenses and reduced net interest expense.

The company has completed footprint actions involving Lanaken, Belgium; its nylon facility in Sakra, Singapore; North American nylon operations; and a compounding facility in Ulsan, South Korea.

Celanese also announced the sale of an additional 19% interest in Nutrinova, with approximately $152 million of cash proceeds expected when the transaction closes in the fourth quarter. Completed and pending transactions represent about two-thirds of the company’s $1 billion divestiture objective through the end of 2027.

The company said it had fully repaid its 2026 debt maturities. It is targeting year-end 2026 net debt of about $10 billion and a leverage ratio of approximately 4.7 times at the midpoint of its guidance, compared with net debt of $11.3 billion and leverage of about six times at the end of 2025. Celanese aims to reduce net debt to below $9 billion by the end of 2027 and expects baseline annual free cash flow of $700 million to $800 million in 2027 and beyond.

For full-year 2026, Celanese maintained adjusted EPS guidance of $6.00 to $6.25 and is targeting approximately 25% adjusted EBIT growth.

The outlook remains subject to demand cycles in automotive, electronics, construction and other end markets, as well as raw-material and energy volatility, pricing pressure, execution of planned cost reductions, debt and refinancing risks, and the company’s ability to realize expected benefits from acquisitions and divestitures. Celanese also identified tariffs, currency and interest-rate movements, geopolitical disruptions, supply-chain interruptions and potential additional asset impairments among its material uncertainties.